Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Florida International University
City of Hope Medical Center
Astellas Pharma Inc
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
University of Iowa
OHSU Knight Cancer Institute
University of Iowa
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of South Florida
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
Indiana University
Ann & Robert H Lurie Children's Hospital of Chicago
Vanderbilt University
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Duke University
National Cancer Institute (NCI)
University of South Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
Children's Oncology Group
National Cancer Institute (NCI)